Get startedLog in
    Picture of Active Biotech AB publ logo

    ACTI — Active Biotech AB publ News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Active Biotech Reports Intriguing Intraocular Levels in Laquinimod Eye Drops Study

    Picture of Active Biotech AB publ logoActive Biotech AB publ
    10/09/2024 07:47
    Sept 10 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACTIVE BIOTECH REPORTS INTRIGUING INTRAOCULAR
CONCENTRATIONS
ACHIEVED IN A CLINICAL BIODISTRIBUTION STUDY OF LAQUINIMOD EYE
DROPS
    * ACTIVE BIOTECH AB PUBL - TOP-LINE RESULTS EXPECTED IN LATE
2024/EARLY 2025

Source text for Eikon:  ID:nMFN59gr24 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Active Biotech AB publ

    See all news